Xilio Therapeutics (XLO) Earnings Date & Reports

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

XLO is expected to report earnings to rise 178.79% to -92 cents per share on November 05

Xilio Therapeutics XLO Stock Earnings Reports

Q3'26

Est.

$-0.92

Q2'26

Beat

by $0.25

Q1'26

Missed

by $0.51

Q4'25

Beat

by $0.88

Q3'25

Missed

by $0.06

The last earnings report on August 12 showed earnings per share of -33 cents, beating the estimate of -57 cents. With 2.50K shares outstanding, the current market capitalization sits at 60.73M.

View a ticker or compare two or three

XLO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days